Mandate

Vinge Advises Sunstone Capital on the Investment in CMC Contrast

February 27, 2008

Vinge advises Sunstone Capital on the investment in CMC Contrast. CMC Contrast develops the CMC 001 product. The product can be found on the market for international pharmaceuticals. The investment will contribute to further the development of the product and continued clinical studies.

Sunstone Capital is represented by partner Johan Winnerblad joined by associate Jonas Bergström.

Related

Vinge has advised Gränges on the refinancing of its sustainability-linked credit facility

Vinge has advised Gränges AB (publ) (“Gränges”), a global leader in aluminium rolling and recycling in selected niches, on the refinancing of its sustainability-linked credit facility, which supports Gränges’ sustainability plan.
February 10, 2025

Vinge has advised Priveq Fund VII in connection with a sustainability-linked credit facility

Priveq Fund VII has entered into a credit facility agreement with Swedbank AB (publ) which will primarily be used to finance the fund’s investment activities. The credit facility is linked to certain of Priveq’s sustainability targets, which means that the interest rate on the credit facility will be adjusted up or down based on the performance of Priveq Fund VII's portfolio companies.
February 10, 2025

Vinge advised ReCarber in financing round

Vinge has advised ReCarber AB in its SEK 60 million financing round. The investors included Luminar Ventures, Spintop Ventures and Course Corrected.
February 10, 2025